Sydney is set to host a state memorial service for Professor Richard Scolyer AO, the revered Australian of the Year and pioneering melanoma pathologist, who passed away on June 7 at the age of 59. The deeply anticipated event will provide an opportunity for the nation to pay its respects to a man whose contributions dramatically reshaped cancer treatment globally, three years after his diagnosis with an incurable brain cancer.
A Legacy Forged in Innovation and Courage
Professor Scolyer, co-medical director of Melanoma Institute Australia, was not merely a brilliant scientist but a beacon of hope and an embodiment of courage. His work, alongside Professor Georgina Long AO, not only transformed melanoma from a death sentence into a largely treatable disease for many but also directly impacted countless lives, both through his research and his compassionate patient care. His decision to undergo experimental treatments for his own glioblastoma, a highly aggressive brain cancer, was a testament to his unwavering commitment to advancing medical knowledge, even in the face of personal adversity. ABC News NSW reported that his innovative approach to his own treatment yielded valuable data that could potentially benefit future brain cancer patients, cementing his legacy not just as a researcher, but as a selfless pioneer.
The Unwavering Fight Against Glioblastoma
Scolyer's battle with glioblastoma became a public and profoundly personal journey that captivated and inspired Australians. Diagnosed in June 2021, he chose to apply the same pioneering immunotherapy techniques he had helped develop for melanoma to his own brain cancer, becoming the first person globally to receive such a regimen. This brave decision, made in consultation with Professor Long, turned his personal tragedy into a living experiment, offering invaluable insights into multimodal immunotherapy for glioblastoma. While ultimately unable to save him, his defiant struggle generated crucial data, pushing the boundaries of what is known about this devastating disease and offering glimmers of hope for future therapies. His commitment to science remained undimmed, even as the disease relentlessly progressed.
A Public Farewell and Enduring Impact
The NSW Premier announced the state memorial service will be held in late July, confirming a date that allows ample time for national arrangements to be made for a fitting tribute. The details surrounding the venue and specific timing are expected to be released in the coming weeks. This public event will undoubtedly draw a significant attendance from across the medical community, political leaders, and the many Australians whose lives were touched by his work or inspired by his resilience. The outpouring of grief and respect following his passing underscored the deep impact he had, not just on the medical profession, but on the national consciousness.
The Australian of the Year: A Fitting Recognition
Professor Scolyer, along with Professor Long, was jointly named Australian of the Year in 2024, a testament to their extraordinary contributions to medical science. This prestigious award acknowledged their groundbreaking work in improving the survival rates for advanced melanoma patients, dramatically changing the prognosis for thousands. The honour, bestowed just months before his death, served as a poignant recognition of a lifetime dedicated to fighting cancer. His acceptance speeches, often delivered with characteristic humility and a fierce dedication to ongoing research, further endeared him to the Australian public, cementing his place as a true national hero whose contributions will resonate for generations.